Halozyme Therapeutics, Inc. (HALO)

Health Care·equity

$110.42

+0.53% today

Extended hours $110.75

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

75/ 100

Score level

High

6 of 6 checks had data

How it compares with the broader market is one of its highest-scoring factors — price trend is one of its highest-scoring factors, while business numbers score (revenue, margins, returns) is near the top of its range.

HALO scores higher than 100% of the 1,101 tickers we compare it with (Health Care).

As of 10 October 2026, Halozyme Therapeutics, Inc. (HALO) scores 75 out of 100 on the Market Census six-factor composite, which puts it at the High score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.

Updated 10 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.81× 30-day average
52-week range: 61.23 – 116.84
Market cap: $12.76B
Earnings date: 2 Nov 2026

Volume: 1,845,336
Avg. volume (30d): 2,288,374

Open: 109.70
Previous close: 109.84
Day's range (regular session): 109.70 – 112.65

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.94
P/E (TTM): 30.40
EPS (TTM): 3.35

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for HALO

50 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for HALO. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about HALO right now

Halozyme Therapeutics, Inc. (HALO) currently scores 75/100 on the Market Census six-factor composite, at the High score level. HALO is +0.53% on the day and +0.51% over five sessions as of the most recent tick. High is the level just below the top. The data for HALO mostly reads well right now. It does not say what happens next. HALO's strongest factor is strength vs the market at 99/100 — a very strong read on how HALO has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is insider trades at 20/100 — a well below average read on insider buying and selling. Insider filings for HALO lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See HALO in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score